These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 5981722

  • 21. [Side-effects of chemotherapeutic agents].
    Mustala O.
    Duodecim; 1970; 86(4):192-202. PubMed ID: 5419251
    [No Abstract] [Full Text] [Related]

  • 22. Pharmocodynamics of lividomycin in renal failure.
    Fillastre JP, Humbert G, Daufresne MF, Dubois D, Leroy A.
    Proc Eur Dial Transplant Assoc; 1973; 10(0):547-50. PubMed ID: 4802558
    [No Abstract] [Full Text] [Related]

  • 23. [The growth hormone and kidney failure: new physiopathological aspects and therapeutic possibilities].
    Díez JJ, Iglesias P, Gómez-Pan A.
    Med Clin (Barc); 1993 Apr 10; 100(14):547-55. PubMed ID: 8469043
    [No Abstract] [Full Text] [Related]

  • 24. [Synthetic anabolic steroids (dimethazine) in osteoporosis].
    Mastrorilli A.
    Minerva Ortop; 1966 Jul 10; 17(7):399-401. PubMed ID: 5918500
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Trial of anabolic agents in cases of chronic renal failure with uremia.
    EL-EBRASHY N, EL-DANASOURY M.
    J Egypt Med Assoc; 1961 Jul 10; Suppl 44():333-9. PubMed ID: 13726294
    [No Abstract] [Full Text] [Related]

  • 27. [Apropos of the indications for anabolic steroids in the treatment of chronic hepatic lesions].
    Blahniková L, Horký J.
    Gastroenterologia; 1967 Jul 10; 107(6):354-9. PubMed ID: 6052562
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Zinc tolerance tests in chronic uremia.
    Antoniou LD, Shalhoub RJ, Elliot S.
    Clin Nephrol; 1981 Oct 10; 16(4):181-7. PubMed ID: 7296977
    [Abstract] [Full Text] [Related]

  • 31. Resistance of the parathyroid glands to vitamin D in renal failure: implications for medical management.
    Fukagawa M, Kitaoka M, Kurokawa K.
    Kidney Int Suppl; 1997 Nov 10; 62():S60-4. PubMed ID: 9350683
    [No Abstract] [Full Text] [Related]

  • 32. Anabolic steroids in the management of chronic wasting diseases.
    Wewalka FG.
    J Am Med Womens Assoc; 1968 Apr 10; 23(4):339-45. PubMed ID: 4231281
    [No Abstract] [Full Text] [Related]

  • 33. The protein metabolite theory as a mechanism for the progression of renal failure.
    Niwa T.
    J Ren Nutr; 2001 Oct 10; 11(4):181-2. PubMed ID: 11679997
    [No Abstract] [Full Text] [Related]

  • 34. [Anabolic steroids in the overall treatment of pulmonary tuberculosis in the middle-aged and elderly].
    Iashchenko BP, Berezitskii AV, Babinskaia IR.
    Probl Tuberk; 1980 Jan 10; (1):26-30. PubMed ID: 7367420
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [On the osteoporosis therapy with anabolic steroids].
    Krüskemper HL.
    Med Welt; 1965 Jun 12; 24():1347. PubMed ID: 5828648
    [No Abstract] [Full Text] [Related]

  • 37. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B, El Nahas M.
    Semin Nephrol; 2009 Jan 12; 29(1):50-8. PubMed ID: 19121474
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The place of anabolic steroids in cancer therapy].
    Host H.
    Tidsskr Nor Laegeforen; 1969 Mar 15; 89(6):417-8. PubMed ID: 5792123
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.